Skip to content

IMMIX BIOPHARMA, INC.: 10-Q filed 2024-08-12

What IMMIX BIOPHARMA, INC. reported in its quarterly report filed 2024-08-12 (fiscal Q2 2024): 40 published measures, 108 facts as tagged in accession 0001493152-24-031358.

This filing

Form
10-Q (quarterly report)
Filed
2024-08-12
Fiscal period
fiscal Q2 2024
Accession
0001493152-24-031358 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IMMIX BIOPHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3028,835,944USD
At 2023-12-3119,925,160USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-304,944,723USD
At 2023-12-313,721,783USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-3023,891,221USD
At 2023-12-3116,405,114USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-3023,975,098USD
At 2023-12-3117,509,791USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-4,392,936USD91
2024-01-01 to 2024-06-30-9,651,927USD182
2023-04-01 to 2023-06-30-3,576,216USD91
2023-01-01 to 2023-06-30-6,055,880USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-9,082,817USD182
2023-01-01 to 2023-06-30-5,607,342USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-06-30398,987USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-12-07 to 2022-12-0820,000,000USD2

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-3015,948,567USD182
2023-01-01 to 2023-06-304,810,576USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-398,987USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-63,063,222USD
At 2023-12-31-53,411,295USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3028,785,223shares91
2024-01-01 to 2024-06-3027,068,513shares182
2023-04-01 to 2023-06-3015,038,989shares91
2023-01-01 to 2023-06-3014,468,373shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3028,785,223shares91
2024-01-01 to 2024-06-3027,068,513shares182
2023-04-01 to 2023-06-3015,038,989shares91
2023-01-01 to 2023-06-3014,468,373shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.15USD/shares91
2024-01-01 to 2024-06-30-0.36USD/shares182
2023-04-01 to 2023-06-30-0.24USD/shares91
2023-01-01 to 2023-06-30-0.42USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.15USD/shares91
2024-01-01 to 2024-06-30-0.36USD/shares182
2023-04-01 to 2023-06-30-0.24USD/shares91
2023-01-01 to 2023-06-30-0.42USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-04-01 to 2024-06-3010,269USD91
2024-01-01 to 2024-06-3019,108USD182
2023-04-01 to 2023-06-306,349USD91
2023-01-01 to 2023-06-3011,519USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-30454,029USD
At 2023-12-3150,181USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-06-301,581,114USD182
2023-01-01 to 2023-06-30777,575USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-4,702,496USD91
2024-01-01 to 2024-06-30-10,292,629USD182
2023-04-01 to 2023-06-30-3,720,711USD91
2023-01-01 to 2023-06-30-6,241,465USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-3027,330,835USD
At 2023-12-3119,787,750USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-303,901,920USD
At 2023-12-313,721,783USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-06-302,346,649USD
At 2023-12-311,433,022USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-304,702,496USD91
2024-01-01 to 2024-06-3010,292,629USD182
2023-04-01 to 2023-06-303,720,711USD91
2023-01-01 to 2023-06-306,241,465USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-302,224,139USD91
2024-01-01 to 2024-06-305,472,808USD182
2023-04-01 to 2023-06-302,209,244USD91
2023-01-01 to 2023-06-303,528,264USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3027,429,197shares
At 2023-12-3119,922,356shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-3086,934,682USD
At 2023-12-3169,779,706USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-06-30116,972USD
At 2023-12-31134,666USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-06-3023,891,221USD
At 2024-03-3127,631,863USD
At 2023-12-3116,203,377USD
At 2023-06-3013,170,573USD
At 2023-03-3111,738,541USD
At 2022-12-3113,159,805USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-06-301,030,662USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-06-301,091,162USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-06-3020,418USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-06-301,375,461USD
At 2023-12-311,105,776USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-4,395,581USD91
2024-01-01 to 2024-06-30-9,717,806USD182
2023-04-01 to 2023-06-30-3,591,863USD91
2023-01-01 to 2023-06-30-6,084,725USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-4,405,850USD91
2024-01-01 to 2024-06-30-9,736,914USD182
2024-01-01 to 2024-03-31-5,331,064USD91
2023-04-01 to 2023-06-30-3,598,212USD91
2023-01-01 to 2023-06-30-6,096,244USD181
2023-01-01 to 2023-03-31-2,498,032USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-4,365,578USD91
2024-01-01 to 2024-06-30-9,669,621USD182
2023-04-01 to 2023-06-30-3,577,881USD91
2023-01-01 to 2023-06-30-6,062,019USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-302,478,357USD91
2024-01-01 to 2024-06-304,819,821USD182
2023-04-01 to 2023-06-301,511,467USD91
2023-01-01 to 2023-06-302,713,201USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-01-01 to 2024-06-306,889USD182
2023-01-01 to 2023-06-301,011USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30306,915USD91
2024-01-01 to 2024-06-30574,823USD182
2023-04-01 to 2023-06-30128,848USD91
2023-01-01 to 2023-06-30156,740USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2024-01-01 to 2024-06-3019,108USD182
2023-01-01 to 2023-06-3011,519USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-01-01 to 2024-06-3015,946,078USD182
2023-01-01 to 2023-06-304,811,393USD181

Inspect the source

Entity
IMMIX BIOPHARMA, INC. / CIK 0001873835
Captured
2026-09-21T17:34:13.242Z
SEC response SHA-256
a042a28a83d019d2522899064f6a9b74a10dc7c16d5e4f2133a259058f7c8420

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001873835.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))